EO decisions and CED recommendations

Information on drug funding decisions based on Executive Officer (EO) decisions and Committee to Evaluate Drugs (CED) recommendations. This information is intended for medical professionals and drug manufacturers.

Additional information

Tags
Geographic coverage
Ontario
Maintainer
Drug Submissions Group, Drug Benefits Management Unit
Last Validated Date
December 5, 2023

EO decisions and CED recommendations

Learn more about accessing data using different formats.

Date range: January 13, 2016 - June 30, 2023

  • CSV
    EO decisions and CED recommendations English [40 KiB]

    Last Updated: December 6, 2023

    Explore

Report an issue with this data

Submit a report if you are experiencing issues with the data resources in this dataset.

Help us improve the Data Catalogue